No Cover Image

Journal article 306 views

Semaglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes / Steve, Bain

Drugs of the Future, Volume: 42, Issue: 8, Start page: 479

Swansea University Author: Steve, Bain

Full text not available from this repository: check for access using links below.

Published in: Drugs of the Future
ISSN: 0377-8282
Published: 2017
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa35930
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2017-10-04T15:45:38Z
last_indexed 2018-10-05T13:21:57Z
id cronfa35930
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2018-10-05T12:33:30.3737221</datestamp><bib-version>v2</bib-version><id>35930</id><entry>2017-10-04</entry><title>Semaglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2017-10-04</date><deptcode>PMSC</deptcode><abstract/><type>Journal Article</type><journal>Drugs of the Future</journal><volume>42</volume><journalNumber>8</journalNumber><paginationStart>479</paginationStart><publisher/><issnPrint>0377-8282</issnPrint><keywords/><publishedDay>1</publishedDay><publishedMonth>8</publishedMonth><publishedYear>2017</publishedYear><publishedDate>2017-08-01</publishedDate><doi>10.1358/dof.2017.042.08.2653526</doi><url/><notes/><college>COLLEGE NANME</college><department>Medicine</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>PMSC</DepartmentCode><institution>Swansea University</institution><lastEdited>2018-10-05T12:33:30.3737221</lastEdited><Created>2017-10-04T11:39:29.4666935</Created><path><level id="1">Swansea University Medical School</level><level id="2">Medicine</level></path><authors><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>1</order></author></authors><documents/></rfc1807>
spelling 2018-10-05T12:33:30.3737221 v2 35930 2017-10-04 Semaglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2017-10-04 PMSC Journal Article Drugs of the Future 42 8 479 0377-8282 1 8 2017 2017-08-01 10.1358/dof.2017.042.08.2653526 COLLEGE NANME Medicine COLLEGE CODE PMSC Swansea University 2018-10-05T12:33:30.3737221 2017-10-04T11:39:29.4666935 Swansea University Medical School Medicine Steve Bain 0000-0001-8519-4964 1
title Semaglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes
spellingShingle Semaglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes
Steve, Bain
title_short Semaglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes
title_full Semaglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes
title_fullStr Semaglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes
title_full_unstemmed Semaglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes
title_sort Semaglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve, Bain
author Steve, Bain
format Journal article
container_title Drugs of the Future
container_volume 42
container_issue 8
container_start_page 479
publishDate 2017
institution Swansea University
issn 0377-8282
doi_str_mv 10.1358/dof.2017.042.08.2653526
college_str Swansea University Medical School
hierarchytype
hierarchy_top_id swanseauniversitymedicalschool
hierarchy_top_title Swansea University Medical School
hierarchy_parent_id swanseauniversitymedicalschool
hierarchy_parent_title Swansea University Medical School
department_str Medicine{{{_:::_}}}Swansea University Medical School{{{_:::_}}}Medicine
document_store_str 0
active_str 0
published_date 2017-08-01T18:54:10Z
_version_ 1650023308434866176
score 10.86698